Kentucky Health Center COVID-19 Survey Summary Report

Latest data from January 14, 2022

Number of Health Center respondents = 23 (92% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 27,043
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) 13.42%
Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 7,484
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) 17.48%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, Antigen)2 Patients Tested Positive, Virus Detection (PCR, Antigen)2
White, Non-Hispanic/Latino Patients 84.88% 80.67%
White, Hispanic/Latino Patients 3.21% 4.37%
Black/African American, Non-Hispanic/Latino Patients 7.50% 9.69%
Black/African American, Hispanic/Latino Patients 0.21% 0.19%
Asian Patients3 0.39% 0.35%
American Indian/Alaska Native Patients3 0.07% 0.11%
Native Hawaiian/Other Pacific Islander Patients3 0.04% 0.04%
Patients with More Than One Race3 1.16% 1.19%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 0.57% 1.16%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 0.33% 0.45%
Unreported/Refused to Report Race and Ethnicity 1.63% 1.79%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 856
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 40.94%
COVID-19 Immunization Series Completed 859
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 43.94%
COVID-19 Immunization Series Additional 2,170
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 31.72%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 48.36% 44.70% 54.75%
White, Hispanic/Latino Patients 12.62% 15.48% 5.62%
Black/African American, Non-Hispanic/Latino Patients 14.49% 12.92% 12.26%
Black/African American, Hispanic/Latino Patients 0.82% 0.00% 0.28%
Asian Patients3 1.29% 1.16% 1.43%
American Indian/Alaska Native Patients3 0.12% 0.23% 0.78%
Native Hawaiian/Other Pacific Islander Patients3 0.12% 0.70% 0.18%
Patients with More Than One Race3 1.52% 2.56% 3.09%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 2.57% 1.98% 1.80%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 0.58% 0.35% 0.74%
Unreported/Refused to Report Race and Ethnicity 17.52% 19.91% 19.08%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)

Metrics Value
Less Than 1 Hour 43.48%
1 to 24 Hours 8.70%
More Than 24 Hours 47.83%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 0.00%
Staffing to administer the vaccine 30.43%
Vaccine confidence 34.78%
Vaccine storage capacity 8.70%
Vaccine supply 13.04%
Other 0.00%
None 26.09%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 21.74%
Average Percent of Health Center Visits Conducted Virtually 16.30%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 39.13%
Number of Mobile Van Sites 3
Number of Pop-up Clinics 28
Number of School-Based Vaccination Sites 1
Number of Family Vaccination Clinics 2

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 13.04%
Refer patients to another organization that provides monoclonal antibody therapies 73.91%
None 17.39%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 4.35%
Patient awareness/education 0.00%
Staffing capacity 4.35%
Therapy administration/onsite logistics 8.70%
Other 0.00%
None 82.61%

Test Kit Distribution

Metrics Value
Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program 3
Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program 7,804

Test Kit Distribution Methods4

Metrics Value
Provide to Existing Health Center Patients 100.00%
Provide to General Public Who Came to the Health Center 33.33%
Provide at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) 0.00%
Provide at Other Community Events 0.00%
Provide through direct outreach to specific populations (i.e., individuals experiencing homelessness, MSAWs, residents of public housing, individuals with limited English proficiency) 0.00%
Other 33.33%

Oral Antiviral Medication Distribution

Metrics Value
Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program 2
Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication5 19.05%

Oral Antiviral Medication Distribution by Race and Ethnicity5

Race/Ethnicity Value
White, Non-Hispanic/Latino Patients 71.43%
White, Hispanic/Latino Patients 9.52%
Black/African American, Non-Hispanic/Latino Patients 0.00%
Black/African American, Hispanic/Latino Patients 0.00%
Asian Patients3 4.76%
American Indian/Alaska Native Patients3 0.00%
Native Hawaiian/Other Pacific Islander Patients3 0.00%
Patients with More Than One Race3 0.00%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 4.76%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 0.00%
Unreported/Refused to Report Race and Ethnicity 4.76%

Oral Antiviral Medication Distribution by Special/Vulnerable Population5

Metrics Value
Migratory/Agricultural Workers 0.00%
Patients Experiencing Homelessness 0.00%
Patients Who Are Residents of Public Housing 0.00%
Patients with Limited English Proficiency 0.00%
Children Under 18 Years of Age 0.00%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.

5 Percentages are calculated using the number of health centers that have distributed courses of COVID-19 oral antiviral medication received through the HRSA Health Center COVID-19 Therapeutics Program as the denominator.

Date Last Reviewed:  January 2022